SGMT
Sagimet Biosciences
$7.45
+$0.38 (+5.37%)Jul 27, 2026
Key metrics
The numbers that frame SGMT today
- Market cap
- $455.82M
- P/E (TTM)
- -10.5
- EV / FCF
- -10.6
- ROIC
- -54.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $4.50
- 52wk High
- $11.41
Growth
Revenue and earnings trend for SGMT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SGMT
Is Sagimet Biosciences a good buy?
No. Sagimet Biosciences has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Sagimet Biosciences is selling at a very high price.
What is the market capitalization of SGMT?
Sagimet Biosciences's market capitalization is $455.82M.
What is the P/E ratio for SGMT stock?
Sagimet Biosciences's current P/E ratio is -10.5.
What is the 52-week high for SGMT stock?
The 52-week high for Sagimet Biosciences is $11.41. The current close of $7.45 is 34.7% below that high.
What is the 52-week low for SGMT stock?
The 52-week low for Sagimet Biosciences is $4.50. The current close of $7.45 is 65.6% above that low.
Does SGMT stock pay dividends?
Sagimet Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SGMT?
Sagimet Biosciences's Debt / Equity ratio is 0.